Observation and Assessment of Pluronic lecithin organogel of Flurbiprofen

International Journal of Pharmacy and Biomedical Engineering

© 2015 by SSRG - IJPBE Journal

Volume 2 Issue 1

Year of Publication : 2015

Authors : Henry John and Landon

10.14445/23942576/IJPBE-V2I1P101

How to Cite?

Henry John and Landon, "Observation and Assessment of Pluronic lecithin organogel of Flurbiprofen," SSRG International Journal of Pharmacy and Biomedical Engineering, vol. 2,  no. 1, pp. 1-4, 2015. Crossref, https://doi.org/10.14445/23942576/IJPBE-V2I1P101

Abstract:

The current work planned to make an index to calculate the typical efficiency of a series of nonsteroidal anti-inflammatory drugs Organogel, a viscoelastic system, can be regarded as a semi-solid preparation which has an immobilized external apolar phase. The apolar phase gets powerless within spaces of the three-dimensional networked arrangement formed due to the physical interactions amongst the self-assembled structures of compounds regarded as gelators. In common, organogels are thermodynamically stable in the environment and have been exploring as matrices for the delivery of bioactive agents. In the current document, attempts have been made to understand the properties of organogels, various types of organogelators, and some applications of the organogels in a controlled delivery.

Keywords:

Organogel, Gel, Gelator, Drug delivery, Biocompatibility.

References:

[1] Ardente, A.J., Barlow, B.M., Burns, P., Goldman, R., Baynes, R.E., 2008. “Vehicle effects on in vitro transdermal absorption of sevoflurane in the bullfrog, Rana catesbeiana”. Environmental Toxicology and Pharmacology. 25, 373–379.
[2] Ansel, H. C., Allen V. L., Popovich G. N., 2001. “Pharmaceutical Dosage Forms and Drug Delivery Systems”. 4, 376 – 380.
[3] Belgamwar, V.S., Pandey, M.S., Chauk, D.S, Surana, S.J., 2008. “Pluronic lecithin organogel”. Asian journal of pharmaceutics. 134-138.
[4] Belgamwar, V.S., Pandey, M.S., Surana, S.J., 2009. “Topical delivery of flurbiprofen from Pluronic Lecithin organogel”. Indian journal of pharmaceutical sciences. 71(1), 87-90.
[5] Byrav P. D. S., Medhi B., Prakash A., Patyar S., Wadhwa S.,2009. “Flurbiprofen: a Newer NSAID”. IJPMR. 20 (1), 27- 31.
[6] Cevc, G., 2004. “Lipid vesicles and other colloids as drug carriers on the skin”. Advanced Drug Delivery Reviews. 56, 675– 711.
[7] Cevc, G., Mazgareanu, S., Rother, M., 2008. “Preclinical characterization of NSAIDs in ultra deformable carriers or conventional topical gels”. International Journal of Pharmaceutics. 360, 29–39.
[8] Chandra, A., Sharma, P.K., Irchhiaya, R.; 2009. “Microemulsion-based hydrogel formulation for transdermal delivery of dexamethasone”. Asian J Pharm. Vol. 3 (1); 30-36.
[9] Dhamankar, A.K., Manwar, J.V., Kumbhar, D.D.; 2009. “The novel formulation design of o/w microemulsion of ketoprofen for improving transdermal absorption”. Int J Pharm Tech Res.Vol. 1(4); 1449-1457.
[10] Dreher, F., Walde, R., Walther, R., Wehrli, E., 1997. “Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport”. Journal of Controlled Release. 45, 131-140.
[11] Dumortier, G., Grossiord, J.L., Agnely, F., Chaumeil, J.C.,2006. “A review of poloxamer 407 pharmaceutical and pharmacological characteristics”. Pharm. Research.12, 2709- 28.
[12] Finch, P.M., Knudsen, L., Drummond, P.D., 2009. “Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine”. International Association for the Study of Pain (Elsevier). 146, 18-25.
[13] Gattani, S.G., Gaud, R.S., Chaturvedi, S.C.; 2006. “Formulation and evaluation of transdermal films of ondansetron hydrochloride”. Indian Drugs. Vol. 43 (3); 245- 251.
[14] Grahame R. “Transdermal non-steroidal anti-inflammatory agents”. Brit. J. Clin. Pract. 1995. 49; 33-35.
[15] Helen, R., Christopher, T., Jenna L., Charles M., 2006. “In-vitro transcutaneous delivery of ketoprofen and polyunsaturated fatty acids from a pluronic lecithin organogel vehicle containing fish oil”. Journal of Pharmacy and Pharmacology, 58(7), 903-908.
[16] Hoffman, S.B., Yoder, A.R., Trepanier, L.A., 2002. “Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats”. J Vet Pharmacol Therapeutics. 25(3), 189-93.
[17] http://en.wikipedia.org/wiki/Gel
[18] http://en.wikipedia.nystatin/wiki
[19] Indurwede, N.H., Biyoni, K.R., Nekhat, P.D., Garg, N., Chopra, V.S., 2001. “Formulation, evaluation, and comparison of gels containing different cox-2 inhibitors”. Indian Journal Medical Sciences. 55, 549-552.
[20] Jain, K.G., Ahmed, F.; 2007. “Adapalene pretreatment increases follicular penetration of clindamycin: In vitro and in vivo studies”. Indian J Dermatol Venereol Leprol. Vol .73(5); 326-329.
[21] Kannaiyan, S., Muthuprasanna, P., Vardhareddy, V.; 2009. “Effect of carbopol gel in stable liposomes and their enhanced antipyretic effect”. Asian J. Pharm.Vol. 3(3); 257- 260.